Sunday, November 18, 2018 1:09:31 PM
My point is that anything is possible, if Dr. Liau made the front page of the New York Times, or a major news presentation on one or more of the networks, the demand for NWBO stock could drive the price to practically anything. Should this occur, I would recommend that investors here today ask the question as to what the stock should reasonably be worth at this time. My answer without the unblinding of the Phase 3 trial data or any other news on other drugs would probably be somewhere between $.5 and $1 billion. If you put the O/S at half a billion, that equates to $1 to $2, but if you allow for all the other warrants etc that are known to be outstanding, it's roughly half those numbers.
So what do investors do. Personally I've been holding things long term and not selling, but if I believe we're reaching what I'll call emotional highs, like $5 or more, even though my shares are still short term holdings, I would probably put in some stop loss orders close to the share price as it rises. While I believe there is no limit as to how high NWBO could go with success with its drugs, especially if its technology is proven to work with multiple cancers, it's premature for it to have a multi billion dollar market cap before at least the top line Phase 3 results are seen. If it goes significantly over a $1 market cap on whatever news occurs Monday, I would think about setting some stop losses, or perhaps just selling part of my holdings with the anticipation of buying them back, and perhaps more, with the proceeds of the sale.
Frankly, it's now been 20 years since an article on curing mice sent a company through the roof, and if anything, we've gone to the other extreme where an article on curing cancer hardly budges stock prices, but there is no telling what new articles or network exposure might do. Dr. Folkman was ultimately successful with some of his ideas, but I don't believe it happened for ENMD, who he was working with when the article came out. I believe the NWBO and Dr. Liau will be very successful, but only time will tell whether NWBO remains independent, or not.
Gary
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM